The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice

Nia, Fatemeh Forooghi; Rahmati, Atefe; Ariamanesh, Mona; Saeidi, Jafar; Ghasemi, Ahmad; Mohtashami, Mahnaz

doi:10.1007/s11274-023-03555-x

Cited by 10 publications

(6 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Different probiotics have different effects on the immune system. (1) Some probiotics also induce the production of anti-inflammatory cytokine (IL-10) and inhibit the secretion of pro-inflammatory cytokine (IL-6, IL-1β, INF-γ), which mediates the inflammatory response in vivo ( Thuy et al, 2022 ; Forooghi Nia et al, 2023 ). Mice infected with H. pylori were fed L. rhamnosus LGG-18 and L. acidophilus Chen-08.…”

Section: Main Treatment Methodsmentioning

confidence: 99%

“…Forooghi Nia et al treated mice positive for H. pylori with Limosilactobacillus reuteri 2892. After 5 weeks, the results showed that the secretion of cytokines such as IL-6, IL-1β, and INF-γ decreased significantly, while the secretion of IL-10 was significantly increased ( Forooghi Nia et al, 2023 ). (2) Probiotics can enhance both the humoral and cellular immune responses in the host by modulating phagocytes and lymphocytes ( Baryshnikova et al, 2023 ).…”

Section: Main Treatment Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review

Liu,

Gao,

Miao

et al. 2024

Front. Microbiol.

View full text Add to dashboard Cite

The global prevalence of Helicobacter pylori (H. pylori) infection remains high, indicating a persistent presence of this pathogenic bacterium capable of infecting humans. This review summarizes the population demographics, transmission routes, as well as conventional and novel therapeutic approaches for H. pylori infection. The prevalence of H. pylori infection exceeds 30% in numerous countries worldwide and can be transmitted through interpersonal and zoonotic routes. Cytotoxin-related gene A (CagA) and vacuolar cytotoxin A (VacA) are the main virulence factors of H. pylori, contributing to its steep global infection rate. Preventative measures should be taken from people’s living habits and dietary factors to reduce H. pylori infection. Phytotherapy, probiotics therapies and some emerging therapies have emerged as alternative treatments for H. pylori infection, addressing the issue of elevated antibiotic resistance rates. Plant extracts primarily target urease activity and adhesion activity to treat H. pylori, while probiotics prevent H. pylori infection through both immune and non-immune pathways. In the future, the primary research focus will be on combining multiple treatment methods to effectively eradicate H. pylori infection.

show abstract

Section: Main Treatment Methodsmentioning

confidence: 99%

Section: Main Treatment Methodsmentioning

confidence: 99%

Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review

Liu,

Gao,

Miao

et al. 2024

Front. Microbiol.

View full text Add to dashboard Cite

show abstract

“…Probiotics containing Lactobacillus acidophilus and Lactobacillus rhamnosus have been shown to reduce the bacterial load of H. pylori according to the 13 C-urea breath test[ 17 ]. The Limosilactobacillus reuteri strain 2892 (L. reuteri 2892) isolated from camel's milk demonstrated the protective effects against H. pylori -induced gastritis in the gastric mucosa in animal models due to significantly downregulated virulence factor cagA gene expression[ 74 ]. The combination of fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra reduced H. pylori density and improved histologic inflammation[ 75 ].…”

Section: Probiotic Monotherapymentioning

confidence: 99%

Probiotics and autoprobiotics for treatment of Helicobacter pylori infection

Baryshnikova,

Ilina,

Ermolenko

et al. 2023

World J Clin Cases

View full text Add to dashboard Cite

Inflammatory myofibroblastic tumor (IMT) of the biliary tract is rare, and often difficult to diagnose or to distinguish from other tumors due to its atypical clinical presentation and nonspecific radiological features. Histologically, IMTs are (myo)fibroblastic neoplasms with a prominent inflammatory infiltrate. They are characterized by receptor tyrosine kinase gene rearrangements, most often involving an anaplastic lymphoma kinase (ALK ) translocation. The final diagnosis of IMT depends on histopathology and immunohistochemical examination. In this manuscript, we provide a clinical and morphomolecular overview of IMT and the difficulties that may arise in using immunohistochemical and molecular techniques in diagnosing IMT.

show abstract

“…Moreover, L. reuteri 2892 reduced the serum concentrations of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and INF-γ and increased the anti-inflammatory cytokine, IL-10. In addition, it showed anti-oxidative stress activity by regulating the levels of SOD and MDA, suggesting that L. reuteri 2892 can attenuate H. pylori -induced gastritis [ 79 ].…”

Section: Limosilactobacillus Speciesmentioning

confidence: 99%

In Vivo Functional Properties of Dairy Bacteria

et al. 2023

View full text Add to dashboard Cite

This literature review aimed to collect investigations on the in vivo evidence for bacteria associated with fermented dairy foods to behave as probiotics with beneficial effects in the prevention and treatment of various diseases. All main bacterial groups commonly present in high numbers in fermented milks or cheeses were taken into account, namely starter lactic acid bacteria (SLAB) Lactobacillus delbrueckii subsp. bulgaricus and lactis, L. helveticus, Lactococcus lactis, Streptococcus thermophilus, non-starter LAB (NSLAB) Lacticaseibacillus spp., Lactiplantibacillus plantarum, dairy propionibacteria, and other less frequently encountered species. Only studies regarding strains of proven dairy origin were considered. Studies in animal models and clinical studies showed that dairy bacteria ameliorate symptoms of inflammatory bowel disease (IBD), mucositis, metabolic syndrome, aging and oxidative stress, cancer, bone diseases, atopic dermatitis, allergies, infections and damage caused by pollutants, mild stress, and depression. Immunomodulation and changes in the intestinal microbiota were the mechanisms most often involved in the observed effects. The results of the studies considered indicated that milk and dairy products are a rich source of beneficial bacteria that should be further exploited to the advantage of human and animal health.

show abstract

The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice

Cited by 10 publications

References 58 publications

Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review

Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review

Probiotics and autoprobiotics for treatment of Helicobacter pylori infection

In Vivo Functional Properties of Dairy Bacteria

Contact Info

Product

Resources

About